Zobrazeno 1 - 10
of 2 453
pro vyhledávání: ''
Publikováno v:
BMJ case reports. 14(11)
This is a case of a young woman who developed neurological and psychiatric symptoms 3 days after resection of an immature teratoma. She was diagnosed with anti-NMDA receptor encephalitis via positive serum antibody titres, which was later confirmed w
Autor:
Pavel Kohout, Jitka Tomesova, Tomas Buchler, Otakar Semerad, Aneta Rozsypalova, Jiri Vejmelka
Publikováno v:
Biomedical Papers. 166:91-96
Background Testicular cancer is associated with excellent prognosis and cure is achieved in most patients with advanced cancer treated with cisplatin-based chemotherapy. However, testicular cancer survivors are at increased risk of accelerated athero
Autor:
Yunyi Kong, Yanchun Meng, Shiyu Jiang, Xin Liu, Jun Cao, Feng Jin, ChunmengWang, Xiaowei Zhang, Zhiguo Luo, Yu Xu, Yong Chen, Huijuan Yang
Publikováno v:
Investigational New Drugs. 40:453-460
Background Mucosal melanoma is rare and has distinct clinical and genetic features. Even with advances in targeted and immune therapies, the survival of patients with advanced or recurrent mucosal melanomas remains poor. The standard treatment remain
Autor:
Seock-Ah Im, Jee Hyun Kim, Jin-Young Jang, Do-Youn Oh, Sae-Won Han, Yung-Jue Bang, Sung W. Ha, Sun Whe Kim, Jihyun Kwon, Eui Kyu Chie, Jae Sung Kim, Tae-You Kim, Kyung-Hun Lee
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose Despite curative resection, the 5-year survival for patients with resectable pancreatic cancer is less than 20%. Recurrence occurs both locally and at distant sites and effective multimodality adjuvant treatment is needed.Materials and Method
Autor:
Yukinori Kurokawa, Junya Fujita, Tomono Kawase, Yutaka Kimura, Hiroshi Imamura, Hisato Kawakami, Masahiro Goto, Kazuhiro Nishikawa, Norimasa Fukushima, Shugo Ueda, Naotoshi Sugimoto, Jin Matsuyama, Taroh Satoh, Daisuke Sakai, Takao Tamura, Toshio Shimokawa
Publikováno v:
International Journal of Clinical Oncology. 26:1871-1880
To compare irinotecan-alone, paclitaxel-alone, and each combination chemotherapy with S-1 in patients with advanced gastric cancer (AGC) that is refractory to S-1 or S-1 plus cisplatin (SP). Patients with AGC after first-line chemotherapy with S-1 or
Autor:
Adity Chakraborty, Shibashis Deb, Amlan Jyoti Nath, Abhinandan Bhattacharjee, Aakanksha Rathor
Publikováno v:
The Egyptian Journal of Otolaryngology, Vol 37, Iss 1, Pp 1-9 (2021)
BackgroundCisplatin is a frontline anticancer drug routinely used as part of concurrent chemoradiation administered at 3-weekly (100 mg/m2) dose. However, its role as fractionated weekly dose has achieved favorable outcome in patients with locally ad
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 14, Iss 2, Pp 972-976 (2021)
Case Reports in Oncology, Vol 14, Iss 2, Pp 972-976 (2021)
We report on a 75-year old man who presented with metastatic, squamous-cell carcinoma (SCC) of the penis whose disease had progressed after radiotherapy (RT) and cisplatin-based chemotherapy (CT). A strong PD-L1 expression as well as a CDKN2A mutatio
Publikováno v:
JGH Open, Vol 5, Iss 6, Pp 705-711 (2021)
JGH Open: An Open Access Journal of Gastroenterology and Hepatology
JGH Open: An Open Access Journal of Gastroenterology and Hepatology
Background and Aim This study investigated the efficacy of transcatheter arterial infusion (TAI) chemotherapy with cisplatin combined with transcatheter arterial chemoembolization (TACE). The goal was to prevent intrahepatic distant recurrence (IDR)
Autor:
Yujin Liu, Kunlin Huang
Publikováno v:
Journal of Interventional Medicine
Journal of Interventional Medicine, Vol 4, Iss 2, Pp 101-104 (2021)
Journal of Interventional Medicine, Vol 4, Iss 2, Pp 101-104 (2021)
A case report of eight year complete remission post bronchial artery infusion (BAI) chemotherapy (Pimetrazine and cisplatin) for unresectable lung adenocarcinoma.
Autor:
Anton Hagenbeek, Julia Driessen, Roberto D Liu, Marcel Nijland, Pauline Brice, Wouter J. Plattel, Roelf Valkema, Thomas Gastinne, Harm van Tinteren, Marie José Kersten, Martin Hutchings, Pieternella J. Lugtenburg, Sanne H. Tonino, Daphne de Jong, Arjan Diepstra, Josée M. Zijlstra, Franck Morschhauser, Marta Lopez-Yurda, Coreline N. Burggraaff, Anne I.J. Arens
Publikováno v:
Haematologica, 106(4), 1129-1137. Ferrata Storti Foundation
Haematologica, 106, 1129-1129
Haematologica
Kersten, M J, Driessen, J, Zijlstra, J M, Plattel, W J, Morschhauser, F, Lugtenburg, P J, Brice, P, Hutchings, M, Gastinne, T, Liu, R, Burggraaff, C N, Nijland, M, Tonino, S H, Arens, A I J, Valkema, R, van Tinteren, H, Lopez-Yurda, M, Diepstra, A, De Jong, D & Hagenbeek, A 2021, ' Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma : the phase II HOVON/LLPC Transplant BRaVE study ', Haematologica, vol. 106, no. 4, pp. 1129-1137 . https://doi.org/10.3324/haematol.2019.243238
Haematologica, 106(4), 1129-1136. FERRATA STORTI FOUNDATION
Haematologica, 106, 4, pp. 1129-1129
Haematologica, 106, 1129-1129
Haematologica
Kersten, M J, Driessen, J, Zijlstra, J M, Plattel, W J, Morschhauser, F, Lugtenburg, P J, Brice, P, Hutchings, M, Gastinne, T, Liu, R, Burggraaff, C N, Nijland, M, Tonino, S H, Arens, A I J, Valkema, R, van Tinteren, H, Lopez-Yurda, M, Diepstra, A, De Jong, D & Hagenbeek, A 2021, ' Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma : the phase II HOVON/LLPC Transplant BRaVE study ', Haematologica, vol. 106, no. 4, pp. 1129-1137 . https://doi.org/10.3324/haematol.2019.243238
Haematologica, 106(4), 1129-1136. FERRATA STORTI FOUNDATION
Haematologica, 106, 4, pp. 1129-1129
Achieving a metabolic complete response (mCR) before high-dose chemotherapy (HDC) and autologous peripheral blood stem cell transplant (auto-PBSCT) predicts progression-free survival (PFS) in relapsed/refractory classical Hodgkin lymphoma (R/R cHL).